Abaloparatide News Today

News and commentary from the endocrinology world

TYMLOS® new patient adds in April: modest growth vs. previous 4-month trailing averages~67% of new patients in April were initiated by a fracture focused bone health accountMeaningful FDA guidance on generic peptide requirements published on May 19, 2021Anticipate abaloparatide depot formulation technical development work to commence 2H, 2021RAD011 Type C meeting with the FDA on Prader Willi Syndrome (“PWS”) the week of June 14 BOSTON, June 02, 2021 (GLOBE NEWSWIRE) -- Radius ...